---
title: "Dietary and Lifestyle Quality Linked to Endometrial Cancer Risk and Survivorship Outcomes"
id: "plos-one-17-dietary-and-lifestyle-quality-and-endometrial-cancer-incidence-and-survivorship"
canonical_url: "https://medichelpline.com/clinical-feed/plos-one-17-dietary-and-lifestyle-quality-and-endometrial-cancer-incidence-and-survivorship"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "PLOS ONE (Medicine)"
source_url: "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0360238"
published_at: "2026-10-14T14:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Dietary and Lifestyle Quality Linked to Endometrial Cancer Risk and Survivorship Outcomes
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/plos-one-17-dietary-and-lifestyle-quality-and-endometrial-cancer-incidence-and-survivorship
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** PLOS ONE (Medicine)
- **Source URL:** [Original Journal Publication](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0360238)
- **Published At:** 2026-10-14T14:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- This umbrella review synthesised 21 systematic reviews (including 15 meta-analyses) that evaluated composite **dietary and lifestyle indices** in relation to endometrial cancer (EC) outcomes. - Primary outcomes assessed included EC incidence (N = 14 reviews), mortality or survival (N = 5), recurrence (N = 4), overall/cancer-specific survival (N = 3), quality of life (QoL) (N = 5), and cardiometabolic events (N = 1). - Evidence grading used an established Ioannidis/Fusar-Poli schema; results were classified from non-significant to weak (class IV) through convincing (class I) based on case numbers, heterogeneity, prediction intervals, and small-study bias. - Pooled case-control data associated adherence to a **Mediterranean diet** with 29% lower odds of EC (pooled OR 0.71, 95% CI 0.51–0.98), graded class IV evidence. - **Western dietary patterns** were associated with a 20% higher odds of EC in pooled analyses (pooled OR 1.20, 95% CI 1.03–1.39), graded class IV evidence. - A combined healthy diet and lifestyle index corresponded to a 46% lower hazard of EC incidence in pooled analyses (pooled HR 0.54, 95% CI 0.42–0.71), graded class III evidence, but heterogeneity across studies was high. - Randomised and non-randomised lifestyle interventions showed no significant effect on global or domain-specific QoL across follow-up durations from nine weeks to 12 months. - Data on recurrence, post-diagnosis survival, mortality, and cardiometabolic consequences remained limited or non-significant; the umbrella review noted insufficient evidence for robust conclusions on these outcomes. - Methodological approach: systematic database search to Dec 3, 2024; AMSTAR 2 quality appraisal; re‑computed random‑effects meta-analyses using the metaumbrella R package; heterogeneity (I2), prediction intervals, Egger’s test for small-study effects, and excess significance bias were evaluated where applicable. - The review preserved cohort versus case-control stratification for some exposures (e.g., MDS) and excluded primary studies with insufficient data from pooled analyses when necessary. - Authors recommended further high-quality research to clarify associations for post-diagnosis outcomes and to reduce heterogeneity and biases in existing pooled estimates.
## Clinical Analysis & Structured Key Points
Dietary and lifestyle quality and endometrial cancer: Incidence and survivorship outcomes—An umbrella review of systematic reviews and meta-analyses | PLOS One Browse Subject Areas ? Click through the PLOS taxonomy to find articles in your field. For more information about PLOS Subject Areas, click here . Article Authors Metrics Comments Media Coverage Reader Comments Figures Figures Abstract Composite dietary and lifestyle indices capture the combined effects of multiple health-related behaviours and may better reflect real-world cancer risk and survivorship than single exposures. This umbrella review aimed to evaluate and grade the strength of evidence for associations between adherence to composite dietary and lifestyle quality indices and endometrial cancer (EC) outcomes, including risk, EC-specific survival, overall survival, disease recurrence, quality of life, and new-onset cardiometabolic diseases. PubMed, Embase, Scopus, Web of Science, CINAHL, and Cochrane Library databases were systematically searched for relevant systematic reviews. Evidence was graded using prespecified umbrella review criteria. A total of 21 systematic reviews were included. Nine investigated diet quality (7 meta-analyses) and 12 investigated lifestyle exposure or interventions (8 meta-analyses). The outcomes assessed were EC risk (N = 14), all-cause or cancer-specific mortality (N = 5), recurrence (N = 4), overall or cancer-specific survival (N = 3), QoL (N = 5), and cardiometabolic events (N = 1). Following a Mediterranean diet was associated with 29% lower odds of EC (pooled OR = 0.71, 95% CI 0.51–0.98; class IV), whereas Western dietary patterns were associated with 20% higher odds of EC (pooled OR = 1.20, 95% CI 1.03–1.39; class IV). A combined healthy diet and lifestyle approach was associated with a 46% lower hazard of EC incidence (pooled HR = 0.54, 95% CI 0.42–0.71; class III), although heterogeneity was high. No significant associations were observed between lifestyle interventions and global or domain-specific quality of life (QoL) across follow-up durations ranging from 9 weeks to 12 months, irrespective of the validated assessment instruments used. Evidence remains limited regarding the associations between diet and lifestyle factors and EC recurrence, survival, mortality, and cardiometabolic outcomes. Our umbrella review identified suggestive (class III–IV) evidence for associations between healthy dietary patterns, particularly the Mediterranean diet, and combined healthy lifestyle approaches with lower EC incidence. Evidence remains insufficient or non‐significant for post-diagnosis outcomes, underscoring the need for further high-quality research. Citation: Al Ramadhani R, Arvin N, Moussa S, Janda M, Playdon MC, Obermair A (2026) Dietary and lifestyle quality and endometrial cancer: Incidence and survivorship outcomes—An umbrella review of systematic reviews and meta-analyses. PLoS One 21(10): e0360238. https://doi.org/10.1371/journal.pone.0360238 Editor: Kazunori Nagasaka, Teikyo University: Teikyo Daigaku, JAPAN Received: October 23, 2025; Accepted: September 24, 2026; Published: October 14, 2026 This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication. Data Availability: All relevant data are within the manuscript and its Supporting Information files. Funding: The author(s) received no specific funding for this work. Competing interests: The authors have declared that no competing interests exist. Introduction Endometrial cancer (EC) is the sixth most common cancer among females worldwide [ 1 ]. Women diagnosed with early-stage EC generally have a good prognosis, with 5-year survival exceeding 90% [ 2 ]. However, their risk of cardiometabolic diseases, cardiovascular death, and other genitourinary conditions is elevated compared with cancer-free females, even when matched for the level of obesity [ 3 – 6 ]. Age-adjusted incidence and mortality rates related to EC are highest in countries with higher human development index (HDI) levels [ 1 ]. The epidemic of obesity in those regions is thought to be a major reason for the observed increase in EC rates [ 1 ]. Yet, increased incidence of and mortality from non-endometrioid ECs that are less obesity-driven but more lethal across racial/ethnic groups suggests other aetiology may be involved as well [ 7 , 8 ]. Currently, no standard screening test is available for the early detection of EC in asymptomatic women, making cancer prevention strategies essential. While evidence suggests that adherence to healthy dietary patterns and lifestyle behaviours may reduce EC risk, findings have been mixed [ 9 ]. The World Cancer Research Fund (WCRF) Continuous Update Project (CUP) identifies energy imbalance, particularly excess body adiposity, as a convincing EC risk factor [ 10 ], with chronic inflammation, elevated estrogen, and hyperinsulinemia proposed as underlying mechanisms [ 11 – 14 ]. Independent of obesity, high dietary glycemic load is associated with increased EC risk, while physical activity and coffee intake appear protective [ 10 ]. A recent umbrella review of 171 meta-analyses reinforced these findings, highlighting strong evidence for obesity and suggestive evidence for physical activity and coffee intake [ 15 ]. However, that review focused on individual risk factors such as specific foods, nutrients, or behaviours rather than evaluating the cumulative effect of overall diet quality or lifestyle patterns. As a result, evidence for broader dietary patterns and lifestyle combinations remains limited and inconclusive [ 10 , 15 ]. In contrast, our umbrella review investigates the collective influence of diet quality indices and lifestyle scores, which reflect adherence to comprehensive health guidelines and capture the synergistic effects of multiple behaviours. This approach provides a more integrated understanding of how combined lifestyle factors relate to EC risk and other outcomes. While certain foods with inflammatory or oxidant properties (e.g., fast food, red and processed meats) have been linked to EC development [ 16 , 17 ], and physical activity contributes to cancer prevention through metabolic regulation [ 18 , 19 ], specific post-diagnosis guidelines for EC survivors remain lacking. Current recommendations largely mirror those for EC prevention [ 10 ]. Although several systematic reviews have assessed individual dietary or lifestyle components in relation to EC risk [ 20 – 31 ], fewer have examined composite indices or cancer prevention guidelines [ 32 – 38 ]. Moreover, most focused solely on EC incidence, with limited attention to outcomes following diagnosis, such as recurrence, survival, quality of life (QoL), or cardiometabolic conditions. This umbrella review therefore seeks to synthesise current evidence on the association between adherence to diet quality or lifestyle guidelines and key EC outcomes. It also aims to critically appraise the strength and consistency of the existing evidence base, identify methodological limitations, and highlight priority areas for future research. The primary objective of this umbrella review was to evaluate the association between adherence to composite indices of dietary and lifestyle quality, and the incidence of EC. Secondary objectives were to assess associations with post-diagnosis outcomes, including recurrence, overall and cancer-specific survival, QoL, and cardiometabolic outcomes. Prespecified indices included commonly used dietary and lifestyle indices, such as the Mediterranean Diet Score (MDS), Healthy Eating Index (HEI), Alternative Healthy Eating Index (AHEI), Dietary Approaches to Stop Hypertension (DASH), World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) score, American Cancer Society (ACS) guidelines, and Healthy Lifestyle Index. We hypothesised that higher adherence to healthier dietary and lifestyle indices would be associated with lower EC incidence, while associations with post-diagnosis outcomes were anticipated to be uncertain given limited and heterogeneous evidence. Methods This systematic umbrella review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [ 39 ] (see Supplementary Checklist S5 in S1 File . PRISMA 2020 checklist). The protocol was registered in PROSPERO (CRD42022312161) on 1 April 2022. No major deviations from the registered protocol occurred, except that no language restrictions were ultimately applied. Search strategy A systematic search of electronic databases, including PubMed, Embase, Cochrane Library, Scopus, CINAHL, and Web of Science from inception to the 3 rd of December 2024 was conducted. The key search terms for exposure included ‘diet*’ OR ‘diet score’ OR ‘diet index’ OR ‘diet quality’ OR ‘dietary guidelines’ OR ‘dietary pattern’ OR ‘dietary change’ OR ‘dietary intervention’ OR ‘dietary modification’ OR ‘lifestyle*’ OR ‘lifestyle modification’ OR ‘lifestyle intervention’ OR ‘healthy lifestyle’. Additionally, phrases like ‘cancer prevention guidelines,’ ‘American Cancer Society,’ and ‘World Cancer Research Fund,’ were incorporated. Outcome terms included ‘endometrial’ or ‘uterine cancer,’ ‘carcinoma,’ ‘tumo(u)r,’ ‘neoplasm,’ and ‘malignancy.’ Filters for ‘systematic review’ and ‘meta-analysis’ were also applied. Additionally, the bibliography of included articles and relevant protocols registered at PROSPERO were searched. Detailed search terms used across different databases are presented in Supplementary Table S1 in S1 File . Selection criteria Inclusion criteria: A pre-defined list of criteria was used to include systematic reviews with or without meta-analyses evaluating the association between adherence to dietary and/or lifestyle recommendations and EC outcomes. The PICOS components of this review’s research question are: Population. Women aged 18 years or older, cancer-free or diagnosed with EC. Intervention/exposure. 1) Diet quality indices including Healthy Eating Index (HEI), Alternative Healthy Eating Index (AHEI), Australian Dietary Guidelines, Mediterranean diet score (MDS), alternate Mediterranean diet score (aMDS), Dietary Approaches to Stop Hypertension (DASH), data-driven dietary patterns (e.g., Western/Prudent), or healthy eating dietary intervention that manipulates more than one food exposure. 2) Lifestyle indices including the American Cancer Society (ACS) Guidelines on nutrition and physical activity for cancer prevention, World Cancer Research Fund/ American Institute for Cancer Research (WCRF/AICR) score, and Healthy Lifestyle index. These indices incorporate key lifestyle factors, including body mass index (BMI), physical activity, smoking status, and dietary intake. Lifestyle interventions typically involve a combination of healthy dietary modifications and increased physical activity. For interventional studies, there were no limits placed on the setting (electronic, telephone or in-person delivery) or the duration and frequency of the intervention. Comparison. High versus low score (observational); No therapeutic/preventive measures or attention control (interventional). Outcome. The primary outcome is EC risk. Secondary outcomes include cancer-specific survival, overall survival, disease recurrence or progression, quality of life, and new-onset cardiometabolic diseases such as hypertension, acute cardiovascular events (stroke, MI), dyslipidaemia, or type 2 diabetes. Study design. All systematic reviews with or without meta-analyses of RCTs, cohort, or case-control studies. Exclusion criteria: Reviews were excluded if they were not systematic reviews or did not focus on human studies. Additionally, if two systematic reviews addressed the same research question using the same primary studies, the most recent or most comprehensive review was included. Although our initial protocol noted the exclusion of non-English reviews, no language filters were applied during the database searches. All included reviews were published in English, reflecting the available literature rather than an enforced exclusion. Reasons for full-text exclusions are reported in the Results. Data extraction Screening of the articles for inclusion was conducted in two steps by two independent reviewers (RA, and NA or SM) at each stage: 1) Screening of titles and abstracts; 2) Full-text review of studies that met the inclusion criteria. Discrepancies between the reviewers were resolved by consensus. Two independent reviewers (RA, and NA or SM) extracted the following data: Author, year, research question, databases and timeframe searched, inclusion/exclusion criteria, primary articles of each review (study numbers, study design, author, year, sample size, age of participants, diet/lifestyle measurement method, mean follow-up), main outcomes including effect estimates of primary studies or pooled effects (for meta-analyses) with respective 95% confidence intervals (CI) and p-values. Data were summarised in an evidence table incorporating all the details listed above. Quality assessment The methodological quality of included studies was assessed by two independent reviewers (RA, and NA or SM) using AMSTAR 2, which is validated and reliable [ 40 , 41 ]. AMSTAR 2 is a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. This is a modified version of AMSTAR and comprises 16 items with an overall quality rating ranging from high or moderate to low, or critically low. AMSTAR 2 results for each included article are presented in a summary table. Disagreements in quality rating were resolved by consensus. Data synthesis For each systematic review, a descriptive analysis was conducted. A structured summary table was formatted with reviews being grouped according to the exposure/ intervention into 1) diet quality indices/patterns, and 2) lifestyle indices/patterns. For each meta-analysis, summary effect sizes with the corresponding 95% CI and p-values were recomputed by fitting a series of random-effects models using the ‘metaumbrella’ package in R (version 4.0.4) (2021) [ 42 ]. All metaumbrella functions in this package require well-formatted datasets containing mandatory variables for each primary study that had been included in previous meta-analyses. Those mandatory variables include “meta-review”, an identifier for the source of the meta-analysis, “factor”, a factor variable which is the intervention/exposure studied, and “author”, “year”, and “measures of effect sizes” for each primary study. The measures of effect sizes in this umbrella review were hazard ratios (HR), odds ratios (OR), and mean differences. Additional required information for each individual study, depending on the effect size measures, was the value of the effect size, the lower and upper bounds of the 95% CI, the total number of participants, the number of cases, the number of controls, the number of exposed participants (exposed cases/controls), and the number of non-exposed participants (non-exposed cases/controls). Continuous outcomes were synthesised as standardised mean differences (SMDs) expressed as Hedges g. Quality of life (QoL) outcomes were assessed using validated instruments reported in the included trials, including the Functional Assessment of Cancer Therapy–General (FACT-G), the Functional Assessment of Cancer Therapy–Fatigue (FACT-F), and the 12-Item Short Form Health Survey (SF-12). Where multiple QoL domains (e.g., physical, emotional, social, fatigue) or time points (e.g., 3 and 6 months) were reported, these were treated as separate outcomes in the synthesis. The Hedges g effect measure was interpreted based on benchmarks developed by Cohen (1988) [ 43 ], where values of 0.2, 0.5, and 0.8 were considered small, medium, and large effects, respectively. For the exposure Mediterranean diet score (MDS) and EC risk outcome, primary studies reported different effect measures. Case-control studies reported odds ratios, whereas a prospective cohort study by George et al. [ 44 ] reported hazard ratios. Because these measures are not directly comparable, we did not pool them. Accordingly, design‑ and effect‑measure–stratified sensitivity analyses were undertaken: case-control studies reporting odds ratios were synthesised quantitatively, while cohort evidence was examined separately and narratively. The cohort study by George et al. [ 44 ] was therefore excluded from the pooled meta‑analysis but retained for sensitivity assessment. The case-control study by Dalvi et al [ 45 ] was excluded due to insufficient data for quantitative synthesis. Additionally, two studies (1 cohort and 1 case-control) were excluded from analyses of Prudent and Western dietary patterns and EC incidence due to insufficient data [ 46 , 47 ]. Moreover, we pooled mean differences from two RCTs measuring QoL using SF-12 physical health on lifestyle intervention at 6-months [ 48 , 49 ]. Those RCTs were included narratively in an updated systematic review with no quantitative synthesis [ 50 ]. For one of the pooled RCTs by Haggerty et al. [ 48 ], we converted medians and quartile ranges to means and SDs based on the method by McGrath (2020) [ 51 ], as this study reported median changes and quartiles only. From the latter RCT, two QoL estimates from two different lifestyle intervention groups that shared a common control group were pooled while adjusting for the shared control group. The umbrella function in the ‘metaumbrella’ package automatically extracted data, performed meta-analyses and additional tests needed: tests for estimating heterogeneity, 95% prediction interval (PI), excess significance bias (ESB), and small-study effects. The Restricted Maximum Likelihood (REML) method was used to estimate the I 2 statistics of heterogeneity. I 2 values of 25%, 50%, and 75% indicated low, moderate, and high heterogeneity, respectively. Egger’s regression asymmetry test was utilised for estimating small-study effects with a p-value 1000, p 1000, p 1000, p < 10 −3 , and class I‐II criteria are not met; weak (class IV) when p < 0.05 and class I‐III criteria are not met; and non‐significant when p ≥ 0.05 [ 52 ]. Overlap assessment A citation matrix was used to display the level of overlap in the primary articles [ 53 ]. The columns in the matrix are the included systematic reviews and the rows are the primary studies for each systematic review. If the outcomes assessed were different across systematic reviews with similar primary articles, then this was not considered overlapping. To quantify overlap, Corrected Cover
## Related Clinical Research

- [Spatial Clustering of CKM Risk Burden Across US Census Tracts: Aging, Environment, and Socioeconom](https://medichelpline.com/clinical-feed/medrxiv-10-aging-structural-and-neighborhood-environmental-correlates-of-cardiovascular.md)
- [Therapeutic patient education reduces one-year major cardiovascular events in Tunisian CHD cohort](https://medichelpline.com/clinical-feed/plos-one-3-evaluation-of-a-therapeutic-education-program-for-patients-with-coronary-heart.md)
- [Helicobacter pylori Serology and Resistant Hypertension: South African Cohort Protocol](https://medichelpline.com/clinical-feed/plos-one-20-protocol-for-investigating-the-association-between-helicobacter-pylori-exposure.md)
- [Medicinal Plants and Diabetic Nephropathy: Phytochemicals, Mechanisms, and Therapeutic Potential](https://medichelpline.com/clinical-feed/frontiers-in-immunology-2-medicinal-plants-in-diabetic-nephropathy-bioactive-compounds-mechanisms-and.md)
- [Fewer than 5% of U.S. Veterans Achieve Optimal Heart Health, AHA Reports](https://medichelpline.com/clinical-feed/aha-news-1-menos-del-5-de-los-veteranos-militares-estadounidenses-podr-an-alcanzar-un.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.